Healthy.Capital

Clear B.V., founded in 2019 and based in Amsterdam, the Netherlands, provides personalized food recommendation plans aimed at promoting healthier lifestyles. The company utilizes intelligent, AI-driven programs to help users manage various aspects of their health, including nutrition, exercise, sleep, and stress. Unlike traditional activity trackers, Clear leverages biomarkers from wearables to deliver precise insights and recommendations. Its programs cater to specific needs, such as diabetes prevention, professional sports performance, and optimizing ketogenic diets. By integrating scientific use cases, Clear offers users actionable guidance rather than mere data, effectively connecting the relationships between sleep, diet, exercise, and stress.

MiGuide is a digital healthcare platform that provides evidence-based coaching and smart technology tools for individuals with type 2 diabetes or obesity. Its programs aim to facilitate sustainable lifestyle changes and improve long-term health.

Clear B.V., founded in 2019 and based in Amsterdam, the Netherlands, provides personalized food recommendation plans aimed at promoting healthier lifestyles. The company utilizes intelligent, AI-driven programs to help users manage various aspects of their health, including nutrition, exercise, sleep, and stress. Unlike traditional activity trackers, Clear leverages biomarkers from wearables to deliver precise insights and recommendations. Its programs cater to specific needs, such as diabetes prevention, professional sports performance, and optimizing ketogenic diets. By integrating scientific use cases, Clear offers users actionable guidance rather than mere data, effectively connecting the relationships between sleep, diet, exercise, and stress.

Orikami B.V., founded in 2011 and based in Nijmegen, the Netherlands, specializes in data science consultancy and digital health solutions tailored for the healthcare industry. The company provides three primary service lines that harness advanced data science expertise, focusing on digital biomarkers and medical-grade technology aimed at chronic disease management. Orikami's artificial intelligence-driven platform facilitates the discovery, validation, and scalable delivery of digital biomarkers, enhancing decision support, treatment strategies, and patient coaching for medical specialists. Committed to data security and quality management, Orikami adheres to ISO27001 and ISO13485 standards in its operations.